Lipocine Inc. (LPCN) — 8-K Filings

8-K Filings (50)

• 8-K Filing — May 7, 2026
• 8-K Filing — Apr 2, 2026
• Lipocine Inc. Files 8-K Report — Apr 2, 2026 Risk: low
  On April 2, 2026, Lipocine Inc. filed an 8-K report detailing other events and financial statements. The filing includes exhibits such as the 8-K form itself an
• 8-K Filing — Dec 16, 2025
• Lipocine Inc. Announces Executive and Board Changes — Dec 15, 2025 Risk: medium
  Lipocine Inc. announced on December 12, 2025, a series of executive and board changes. Dr. Richard Walovitch has been appointed as Chief Medical Officer, and Dr
• Lipocine Inc. Files 8-K for Financials and Exhibits — Dec 11, 2025 Risk: low
  Lipocine Inc. filed an 8-K on December 11, 2025, reporting on events that occurred on December 8, 2025. The filing primarily concerns financial statements and e
• 8-K Filing — Nov 18, 2025
• Lipocine Inc. Files 8-K Report — Nov 4, 2025 Risk: low
  Lipocine Inc. filed an 8-K on November 4, 2025, reporting other events and financial statements. The company, formerly known as Marathon Bar Corp until November
• Lipocine Inc. Files 8-K Report — Sep 30, 2025 Risk: low
  Lipocine Inc. filed an 8-K report on September 30, 2025, primarily to disclose other events and financial statements. The filing does not detail specific transa
• Lipocine Inc. Files 8-K — Sep 26, 2025 Risk: low
  Lipocine Inc. filed an 8-K on September 26, 2025, reporting on other events and financial statements. The filing does not detail specific transactions or financ
• Lipocine Inc. Files 8-K — Sep 5, 2025 Risk: low
  Lipocine Inc. filed an 8-K on September 5, 2025, reporting on other events and financial statements. The filing does not detail specific transactions or financi
• Lipocine Inc. Files 8-K — Aug 26, 2025 Risk: low
  Lipocine Inc. filed an 8-K on August 26, 2025, reporting other events and financial statements. The company, previously known as Marathon Bar Corp until Novembe
• Lipocine Inc. Files 8-K Report — Jul 9, 2025 Risk: low
  Lipocine Inc. filed an 8-K on July 9, 2025, reporting other events and financial statements. The company, previously known as Marathon Bar Corp until November 3
• Lipocine Inc. Files 8-K Report — Jul 2, 2025 Risk: low
  Lipocine Inc. filed an 8-K on July 2, 2025, reporting other events and financial statements. The company, formerly known as Marathon Bar Corp until November 30,
• Lipocine Inc. Files 8-K Report — Jun 26, 2025 Risk: low
  Lipocine Inc. filed an 8-K on June 26, 2025, reporting other events and financial statements. The filing does not contain specific details about new material ev
• Lipocine Inc. Files 8-K Report — Jun 23, 2025 Risk: low
  Lipocine Inc. filed an 8-K on June 23, 2025, reporting other events and financial statements. The company, previously known as Marathon Bar Corp until November
• Lipocine Inc. Files 8-K — Jun 9, 2025 Risk: low
  Lipocine Inc. filed an 8-K on June 9, 2025, reporting other events and financial statements. The company, previously known as Marathon Bar Corp until November 3
• Lipocine Inc. Files 8-K with Corporate Updates — Jun 4, 2025 Risk: low
  Lipocine Inc. filed an 8-K on June 4, 2025, reporting on amendments to its articles of incorporation or bylaws, submission of matters to a vote of security hold
• Lipocine Inc. Files 8-K — May 22, 2025 Risk: low
  Lipocine Inc. filed an 8-K on May 22, 2025, reporting other events and financial statements. The company, previously known as Marathon Bar Corp until November 3
• Lipocine Inc. Files 8-K for Other Events and Exhibits — May 14, 2025 Risk: low
  Lipocine Inc. filed an 8-K on May 14, 2025, reporting on other events and financial statements. The filing does not detail specific transactions or financial fi
• 8-K Filing — May 12, 2025
• Lipocine Inc. Files 8-K Report — May 6, 2025 Risk: low
  Lipocine Inc. filed an 8-K on May 6, 2025, reporting other events and financial statements. The company, previously known as Marathon Bar Corp until November 30
• 8-K Filing — Apr 3, 2025
• Lipocine Inc. Files 8-K: Procedural Update — Mar 26, 2025 Risk: low
  Lipocine Inc. filed an 8-K on March 26, 2025, reporting on other events and financial statements. The filing does not contain specific details about new events,
• Lipocine Inc. Files 8-K Report — Mar 12, 2025 Risk: low
  On March 12, 2025, Lipocine Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates o
• Lipocine Inc. Files 8-K — Feb 11, 2025 Risk: low
  Lipocine Inc. filed an 8-K on February 11, 2025, reporting other events and financial statements. The filing does not contain specific details about new events,
• Lipocine Inc. Files 8-K — Feb 6, 2025 Risk: low
  Lipocine Inc. filed an 8-K on February 6, 2025, reporting other events and financial statements. The filing does not contain specific details about new material
• Lipocine Inc. Files 8-K Report — Jan 13, 2025 Risk: low
  Lipocine Inc. filed an 8-K on January 13, 2025, reporting other events and financial statements. The filing does not contain specific financial figures or mater
• Lipocine Inc. Files 8-K: Other Events & Financials — Dec 17, 2024 Risk: low
  Lipocine Inc. filed an 8-K on December 17, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not detail specific transacti
• Lipocine Inc. Files 8-K with Office and Contact Details — Dec 13, 2024 Risk: low
  Lipocine Inc. filed an 8-K on December 13, 2024, reporting an event. The filing details the company's principal executive offices located at 675 Arapeen Drive,
• Lipocine Inc. Files 8-K: Other Events & Exhibits — Nov 18, 2024 Risk: low
  Lipocine Inc. filed an 8-K on November 18, 2024, reporting other events and financial statements. The company, previously known as Marathon Bar Corp until Novem
• Lipocine Inc. Files 8-K for Corporate Updates — Nov 5, 2024 Risk: low
  Lipocine Inc. filed an 8-K on November 5, 2024, reporting other events and financial statements. The company, incorporated in Delaware with its principal execut
• Lipocine Inc. Files 8-K — Oct 31, 2024 Risk: low
  Lipocine Inc. filed an 8-K on October 31, 2024, reporting an "Other Event" and "Financial Statements and Exhibits" as of October 28, 2024. The filing does not c
• Lipocine Inc. Files 8-K for Material Agreements — Oct 23, 2024 Risk: medium
  On October 22, 2024, Lipocine Inc. entered into a material definitive agreement. The company also made modifications to the rights of its security holders and a
• 8-K Filing — Oct 16, 2024
• Lipocine Inc. Files 8-K — Oct 10, 2024 Risk: low
  Lipocine Inc. filed an 8-K on October 10, 2024, reporting other events and financial statements. The filing does not contain specific details about new events,
• 8-K Filing — Oct 8, 2024
• Lipocine Inc. Files 8-K — Oct 2, 2024 Risk: low
  Lipocine Inc. filed an 8-K on October 2, 2024, reporting other events and financial statements. The company, incorporated in Delaware with its principal executi
• Lipocine Inc. Files 8-K for Other Events and Exhibits — Sep 30, 2024 Risk: low
  Lipocine Inc. filed an 8-K on September 30, 2024, reporting other events and financial statements. The filing does not detail specific transactions or material
• Lipocine Inc. Files 8-K for Other Events — Sep 5, 2024 Risk: low
  Lipocine Inc. filed an 8-K on September 5, 2024, to report other events and financial statements. The filing does not contain specific details about new events
• Lipocine Inc. Files 8-K — Aug 27, 2024 Risk: low
  Lipocine Inc. filed an 8-K on August 27, 2024, reporting other events and financial statements. The filing does not contain specific details on new events, doll
• Lipocine Inc. to Acquire Neuro-Bio Ltd. — Jun 25, 2024 Risk: medium
  Lipocine Inc. announced on June 25, 2024, that it has entered into a definitive agreement to acquire all outstanding equity interests of privately held company,
• Lipocine Inc. Files 8-K — Jun 10, 2024 Risk: low
  Lipocine Inc. filed an 8-K on June 10, 2024, reporting other events and financial statements/exhibits as of June 8, 2024. The filing does not contain specific d
• Lipocine Inc. Files 8-K on Shareholder Votes and Financials — Jun 5, 2024 Risk: low
  Lipocine Inc. filed an 8-K on June 5, 2024, reporting on the submission of matters to a vote of security holders and financial statements. The company, incorpor
• Lipocine Inc. Files 8-K: Other Events & Financials — May 8, 2024 Risk: low
  Lipocine Inc. filed an 8-K on May 8, 2024, reporting other events and financial statements. The company, previously known as Marathon Bar Corp until November 30
• Lipocine Inc. Files 8-K: Other Events & Exhibits — May 1, 2024 Risk: low
  Lipocine Inc. filed an 8-K on May 1, 2024, reporting other events and financial statements. The company, previously known as Marathon Bar Corp until November 30
• Lipocine Inc. Files 8-K Report — Apr 29, 2024 Risk: low
  Lipocine Inc. filed an 8-K on April 29, 2024, reporting on other events and financial statements. The company, previously known as Marathon Bar Corp until Novem
• Lipocine Inc. Files 8-K: Material Agreements Entered and Terminated — Apr 26, 2024 Risk: medium
  On April 26, 2024, Lipocine Inc. entered into a Material Definitive Agreement and also terminated a Material Definitive Agreement. The company, incorporated in
• Lipocine Inc. Files 8-K Report — Apr 11, 2024 Risk: low
  On April 11, 2024, Lipocine Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates o
• Lipocine Inc. Files 8-K Report — Mar 28, 2024 Risk: low
  Lipocine Inc. filed an 8-K on March 28, 2024, reporting on other events and financial statements. The filing does not contain specific details about new materia

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX